欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/2280/002
药品名称
Movevit
活性成分
mesalazine 1000.0 mg
剂型
Suppository
上市许可持有人
Laboratórios Vitória, S.A.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Denmark (DK)
Sweden (SE)
Norway (NO)
Mesalazin Orion
Finland (FI)
Bulgaria (BG)
Cyprus (CY)
Mecolzine 1g suppositories
Malta (MT)
许可日期
2020/01/29
最近更新日期
2024/02/22
药物ATC编码
A ALIMENTARY TRACT AND METABOLISM
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
1.3.1 common-outer-1g
Date of last change:2020/12/22
Final Product Information
|
1.3.1 common-pl-1g
Date of last change:2020/12/22
Final Product Information
|
1.3.1 common-spc-1g
Date of last change:2020/12/22
PAR
|
2280_Movevit_PAR_3FEV2020
Date of last change:2020/12/22
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase